1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with fluorescein-5-isothiocyanate in 19 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 8,493 | 33 | 2,090 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.53) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewis, SA; Raeburn, D; Underwood, SL | 1 |
| Bethel, RA; Henson, PM; Lien, DC; Worthen, GS | 1 |
| Erjefält, I; Luts, A; Persson, CG; Sundler, F | 1 |
| Appleby, P; Bowen, JG | 1 |
| Dillon, PK; Durán, WN | 1 |
| Grewal, IS; Lad, PM; Olson, CV | 1 |
| Abelli, L; Evangelista, S; Manzini, S; Page, CP; Perretti, F; Seeds, EA | 1 |
| Hidaka, T; Ishizuka, T; Kawaguchi, Y; Kawakami, M; Matsuki, Y; Nakamura, H; Suzuki, K | 1 |
| Durán, WN; Fallek, SR; Hobson, RW; Noel, AA | 1 |
| Durán, WN; Hobson, RW; Kim, D; Kobayashi, I; Oshiro, H; Takenaka, H | 1 |
| Argenbright, LW; Granger, DN; Kurose, I; Wolf, R | 1 |
| Byrum, RS; Goulet, JL; Griffiths, RJ; Koller, BH; Snouwaert, JN | 1 |
| Anderson, DE; Klabunde, RE | 1 |
| Jin, Y; Ouyang, HM; Song, JX; Su, M; Tai, H; Wang, WY; Wei, Q; Xiong, YL; Zhang, Y; Zhou, XD | 1 |
| Bossi, F; Bulla, R; Ferrero, E; Fischetti, F; Mollnes, TE; Pellis, V; Regoli, D; Tedesco, F | 1 |
| Abele, H; Akel, A; Attanasio, P; Bachmann, C; Bachmann, R; Gatz, S; Hermle, T; Huber, S; Kempe, DS; Lang, F; Lang, PA; Podolski, M; Shumilina, E; Wieder, T | 1 |
| Byrne, SN; Matsumura, Y; Miyahara, Y; Nghiem, DX; Ullrich, SE | 1 |
| Durán, RG; Durán, WN; Kim, DD; Meininger, CJ; Sánchez, FA | 1 |
| Bai, XD; Guo, SJ; Hu, S; Hu, XH; Li, ZY; Liu, R; Wang, SM; Zhou, FQ | 1 |
19 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
RP 58802B, a long-acting beta 2-adrenoceptor agonist: assessment of antiasthma activity in the guinea-pig in vivo.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Albuterol; Anesthesia; Animals; Antigens; Asthma; Benzimidazoles; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Dextrans; Ethanolamines; Fluorescein-5-isothiocyanate; Guinea Pigs; Histamine; Male; Platelet Activating Factor; Time Factors; Trachea | 1992 |
Platelet-activating factor causes neutrophil accumulation and neutrophil-mediated increased vascular permeability in canine trachea.
Topics: Animals; Capillary Permeability; Cell Separation; Dogs; Female; Fluorescein-5-isothiocyanate; Male; Microscopy, Fluorescence; Neutrophils; Perfusion; Platelet Activating Factor; Time Factors; Trachea | 1992 |
The airway epithelial lining in guinea pigs is intact promptly after the mucosal crossing of a large amount of plasma exudate.
Topics: Animals; Bronchi; Bronchial Provocation Tests; Capsaicin; Dextrans; Epithelium; Exudates and Transudates; Fluorescein-5-isothiocyanate; Fluoresceins; Guinea Pigs; Male; Microscopy, Fluorescence; Mucous Membrane; Plasma; Platelet Activating Factor; Trachea | 1990 |
Cutaneous inflammatory disorders.
Topics: Animals; Calmodulin; Dermatitis; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Humans; Interleukin-1; Oxazolone; Phospholipases A; Picryl Chloride; Platelet Activating Factor; Thiocyanates | 1990 |
Effect of platelet-activating factor on microvascular permselectivity: dose-response relations and pathways of action in the hamster cheek pouch microcirculation.
Topics: Animals; Benzofurans; Blood Pressure; Capillary Permeability; Cheek; Cricetinae; Dexamethasone; Dextrans; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Fluoresceins; Hematocrit; Indomethacin; Lignans; Macromolecular Substances; Male; Mesocricetus; Methacrylates; Microcirculation; Platelet Activating Factor | 1988 |
A step sensitive to pertussis toxin and phorbol ester in human neutrophils regulates chemotaxis and capping but not phagocytosis.
Topics: Chemotaxis, Leukocyte; Concanavalin A; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; Humans; Kinetics; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pertussis Toxin; Phagocytosis; Phorbols; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Virulence Factors, Bordetella | 1986 |
Isbufylline, a new xanthine derivative, inhibits airway hyperresponsiveness and airway inflammation in guinea pigs.
Topics: 1-Methyl-3-isobutylxanthine; Acetylcholine; Albuterol; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Capsaicin; Dextrans; Dyspnea; Fluorescein-5-isothiocyanate; Guinea Pigs; Histamine; Leukocytes; Male; Ovalbumin; Platelet Activating Factor | 1993 |
DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Cell Division; Cells, Cultured; Cycloheximide; Endothelium, Vascular; Epoprostenol; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Platelet Activating Factor; Prostaglandin Endoperoxides, Synthetic; Recombinant Proteins; Tetrahydronaphthalenes; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Tumor Necrosis Factor-alpha; Umbilical Veins | 1994 |
Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
Topics: Animals; Arginine; Capillary Permeability; Cheek; Cricetinae; Cromolyn Sodium; Dextrans; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Histamine; Inflammation; Macrophage-1 Antigen; Male; Mast Cells; Mesocricetus; Microcirculation; Microscopy, Video; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor | 1995 |
L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo.
Topics: Animals; Calcium Channel Blockers; Capillary Permeability; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Male; Mesocricetus; Nifedipine; Platelet Activating Factor; Spectrometry, Fluorescence; Vasoconstriction; Verapamil | 1995 |
Oxidative stress during platelet-activating factor-induced microvascular dysfunction.
Topics: Animals; Antibodies, Monoclonal; Capillary Permeability; Catalase; Cell Adhesion; Cell Adhesion Molecules; Fluorescein-5-isothiocyanate; Hydrogen Peroxide; Leukocytes; Male; Mesentery; Microcirculation; Microscopy, Video; Oxidation-Reduction; Oxidative Stress; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Rhodamines; Serum Albumin, Bovine; Thiourea | 1996 |
Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
Topics: Acute Disease; Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Movement; Crosses, Genetic; Cysteine; Dermatitis, Contact; Ear; Epoxide Hydrolases; Fluorescein-5-isothiocyanate; Immunoglobulin E; Inflammation Mediators; Leukotriene B4; Leukotrienes; Lipopolysaccharides; Mice; Mice, Knockout; Neutrophils; Peritonitis; Platelet Activating Factor | 1999 |
Obligatory role of nitric oxide in platelet-activating factor-induced microvascular leakage.
Topics: Animals; Capillary Permeability; Cheek; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Male; Mesocricetus; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Penicillamine; Platelet Activating Factor; Vasoconstriction; Vasodilator Agents | 2000 |
TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb.
Topics: Animals; Crotalid Venoms; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Lectins, C-Type; Metalloendopeptidases; Platelet Activating Factor; Platelet Activation; Platelet Glycoprotein GPIb-IX Complex; Trimeresurus; Viper Venoms | 2004 |
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex.
Topics: Animals; Bradykinin; Capillary Permeability; Cell Line; Complement Membrane Attack Complex; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Humans; Ileum; Intercellular Junctions; Male; Mesentery; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred WKY; Serum Albumin, Bovine; Solubility | 2004 |
Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes.
Topics: Adult; Aging; Aniline Compounds; Annexin A5; Apoptosis; Calcium; Cations; Cell Separation; Chlorides; Cytosol; Dinoprostone; Erythrocytes; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Infant, Newborn; Ion Channels; Osmotic Pressure; Oxidative Stress; Patch-Clamp Techniques; Phosphatidylserines; Platelet Activating Factor; tert-Butylhydroperoxide; Xanthenes | 2006 |
A role for inflammatory mediators in the induction of immunoregulatory B cells.
Topics: Adoptive Transfer; Animals; Antigens, CD19; B-Lymphocytes; Dermatitis, Contact; Dihydropyridines; Flow Cytometry; Fluorescein-5-isothiocyanate; Immune Tolerance; Inflammation; Interleukin-10; Leukocyte Common Antigens; Lymphocyte Activation; Mice; Mice, Mutant Strains; Platelet Activating Factor; Serotonin; Serotonin Antagonists; Ultraviolet Rays | 2006 |
Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules.
Topics: Animals; Capillary Permeability; Cattle; Caveolae; Cells, Cultured; Dextrans; Dynamin II; Endocytosis; Endothelial Cells; Fluorescein-5-isothiocyanate; Inflammation; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Platelet Activating Factor; RNA Interference; RNA, Small Interfering; Time Factors; Transfection | 2008 |
Pyruvate in oral rehydration salt improves hemodynamics, vasopermeability and survival after burns in dogs.
Topics: Animals; Bicarbonates; Burns; Capillary Permeability; Disease Models, Animal; Dogs; Fluid Therapy; Fluorescein-5-isothiocyanate; Glucose; Hemodynamics; Lactic Acid; Platelet Activating Factor; Potassium Chloride; Pyruvic Acid; Random Allocation; Shock; Sodium Chloride; Vascular Endothelial Growth Factor A | 2016 |